search
Back to results

Copenhagen Study of Obese Patients With Ischemic Heart Disease Undergoing Low Energy Diet or Interval Training (CUT-IT)

Primary Purpose

Ischemic Heart Disease, Obesity

Status
Completed
Phase
Not Applicable
Locations
Denmark
Study Type
Interventional
Intervention
Interval Training
Weight Loss
Sponsored by
Eva Prescott
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Ischemic Heart Disease focused on measuring Interval Training, Weight Loss, Secondary Prevention, Rehabilitation, Cardiovascular Risk Factors

Eligibility Criteria

45 Years - 75 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Stable Ischemic Heart Disease
  • BMI 28 - 40 kg/m2

Exclusion criteria:

  • Known Diabetes Mellitus
  • Repeated Fasting plasma glucose ≥ 7 mmol/L or Hba1c > 7 %
  • Severe or moderate valve disease
  • Main stem stenosis
  • Severe heart failure, Ejection Fraction < 35 %
  • Physical or mental disability which are expected to prevent completion of intervention
  • Severe Chronic obstructive Pulmonary Disease (COPD) (FEV1 < 50 % of expected) or asthma
  • Active cancer
  • Severe kidney (GFR < 40 ml/hour) or severe liver disease
  • Severe ischemia or arrhythmias during exercise test
  • 2. or 3. degree atrio-ventricular (AV) block, not protected by pacemaker
  • Organised training more than 2 times a week prior to inclusion
  • Significant weight loss or weight gain (> 5 %)3 month prior to inclusion
  • Not able to comprehend written and oral informed consent
  • Hormone treatment

Sites / Locations

  • Bispebjerg Hospital

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Experimental

Arm Label

Weight Loss

Interval Training

Arm Description

12 weeks of Low Calorie Diet to obtain a 10 - 15 % weight loss. Followed by 40 weeks on a weight maintenance diet and interval training 2 times a week.

12 weeks of interval training 3 times a week followed by 40 weeks of interval training 2 times a week.

Outcomes

Primary Outcome Measures

Change in Coronary Flow Reserve following the diet or training intervention and a maintenance period
Assessed by a non-invasive echocardiographic Doppler measurement

Secondary Outcome Measures

Change in Heart Rate Variability and silent ischemia following the diet or training intervention and a maintenance period
Assessed by Holter Monitoring for 24 - 48 hours
Change in endothelial function following the diet or training intervention and a maintenance period
Using the Endopat 2000 from Itamar
Change in systolic and diastolic function following the diet or training intervention and a maintenance period
Assessed by echocardiography resting and during physiological and medical stress.
Change in body composition following the diet or training intervention and a maintenance period
Assessed by anthropometry, dual X-ray absorptiometry (DXA) (lean body mass, percentage adipose tissue) and abdominal MRI (liver fat, muscle fat, subcutaneous fat and visceral fat at the level of L3).
Change in myocardial blood flow following the diet or training intervention and a maintenance period
Assessed by positron emission tomography of the heart
Change in insulin action, beta cell function and incretin secretion following the diet or training intervention and a maintenance period
A Oral Glucose Tolerance Test is performed.
Change in oxidized lipids and lipoprotein particle size following the diet or training intervention and a maintenance period
Change in peak oxygen uptake (VO2max) following the diet or training intervention and a maintenance period
Assessed using a bicycle ergometer
Change in blood pressure following the diet or training intervention and a maintenance period
Change in inflammatory markers in urin, blood and adipose tissue following the diet or training intervention and a maintenance period
Change in quality of life following the diet or training intervention and a maintenance period
Change in ceramides, diacylglycerol og endocannabinoid (CB)-1 receptors in adipose tissue following the diet or training intervention and a maintenance period
Change in hormones derived from adipose tissue following the diet or training intervention and a maintenance period

Full Information

First Posted
October 26, 2012
Last Updated
August 3, 2014
Sponsor
Eva Prescott
Collaborators
University of Copenhagen, Amager Hospital, Bispebjerg Hospital, Copenhagen University Hospital at Herlev, Copenhagen University Hospital, Hvidovre, Rigshospitalet, Denmark, University of California, Davis, Texas A&M University, University of Aarhus
search

1. Study Identification

Unique Protocol Identification Number
NCT01724567
Brief Title
Copenhagen Study of Obese Patients With Ischemic Heart Disease Undergoing Low Energy Diet or Interval Training
Acronym
CUT-IT
Official Title
Copenhagen Study of Obese Patients With Ischemic Heart Disease Undergoing Low Energy Diet or Interval Training: A Randomized Clinical Trial
Study Type
Interventional

2. Study Status

Record Verification Date
August 2014
Overall Recruitment Status
Completed
Study Start Date
September 2011 (undefined)
Primary Completion Date
April 2014 (Actual)
Study Completion Date
April 2014 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor-Investigator
Name of the Sponsor
Eva Prescott
Collaborators
University of Copenhagen, Amager Hospital, Bispebjerg Hospital, Copenhagen University Hospital at Herlev, Copenhagen University Hospital, Hvidovre, Rigshospitalet, Denmark, University of California, Davis, Texas A&M University, University of Aarhus

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
The purpose of the study is to make a head-to-head comparison of weight loss and interval training as methods of secondary prevention in overweight patients with ischemic heart disease.
Detailed Description
In western countries 80 % of patients with ischemic heart disease (IHD) are overweight (BMI > 25). Weight loss using a low energy diet (LED, 800 - 1000 kcal/day) has been shown to induce a considerable weight loss in obese but otherwise healthy patients and to reduce the risk of cardiovascular disease and diabetes in these subjects. Additionally, a British study using a very low energy diet (VLED, 600 kcal/day) to obtain weight loss, has shown that subject with diagnosed type 2 diabetes had their blood glucose normalized after an 8 week VLED. However, the effect of LED has never been examined in overweight patients with IHD. Several studies have shown that patients with IHD have a beneficial effect of exercise training regarding mortality and reduction in cardiovascular risk factors. A Norwegian group has shown that aerobic interval training results in the biggest increase in maximal oxygen uptake (VO2max). A high VO2max is correlated to decreased mortality in patients with IHD. In conclusion, weight loss and exercise are known strategies in preventing progression of IHD and development of type 2 diabetes in these patients, however a head-to-head comparison of the two methods has never been made and it is unknown which intervention is the most effective in improving cardiovascular risk profile. Furthermore, several mechanisms behind the known beneficial effect of these interventions are unknown.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Ischemic Heart Disease, Obesity
Keywords
Interval Training, Weight Loss, Secondary Prevention, Rehabilitation, Cardiovascular Risk Factors

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
70 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Weight Loss
Arm Type
Experimental
Arm Description
12 weeks of Low Calorie Diet to obtain a 10 - 15 % weight loss. Followed by 40 weeks on a weight maintenance diet and interval training 2 times a week.
Arm Title
Interval Training
Arm Type
Experimental
Arm Description
12 weeks of interval training 3 times a week followed by 40 weeks of interval training 2 times a week.
Intervention Type
Other
Intervention Name(s)
Interval Training
Intervention Description
Interval training (IT) on an exercise bike 3 times a week, for the first 12 weeks, followed by 40 weeks of IT 2 times a week on exercise bike. Each training session consists of active intervals with a total duration of 16 minutes (durations intervals between 1 and 4 minutes) at 90% of maximal heart rate. Active intervals are separated by active pauses at 60% of maximal heart rate.
Intervention Type
Other
Intervention Name(s)
Weight Loss
Intervention Description
Low calorie diet approx. 1000 kcal/day for 8 - 10 weeks to obtain a 10 - 15 % weight loss.
Primary Outcome Measure Information:
Title
Change in Coronary Flow Reserve following the diet or training intervention and a maintenance period
Description
Assessed by a non-invasive echocardiographic Doppler measurement
Time Frame
0, 12 and 52 weeks
Secondary Outcome Measure Information:
Title
Change in Heart Rate Variability and silent ischemia following the diet or training intervention and a maintenance period
Description
Assessed by Holter Monitoring for 24 - 48 hours
Time Frame
0, 12 and 52 weeks
Title
Change in endothelial function following the diet or training intervention and a maintenance period
Description
Using the Endopat 2000 from Itamar
Time Frame
0, 12 and 52 weeks
Title
Change in systolic and diastolic function following the diet or training intervention and a maintenance period
Description
Assessed by echocardiography resting and during physiological and medical stress.
Time Frame
0, 12 and 52 weeks
Title
Change in body composition following the diet or training intervention and a maintenance period
Description
Assessed by anthropometry, dual X-ray absorptiometry (DXA) (lean body mass, percentage adipose tissue) and abdominal MRI (liver fat, muscle fat, subcutaneous fat and visceral fat at the level of L3).
Time Frame
0, 12 and 52 weeks
Title
Change in myocardial blood flow following the diet or training intervention and a maintenance period
Description
Assessed by positron emission tomography of the heart
Time Frame
0, 12 and 52 weeks
Title
Change in insulin action, beta cell function and incretin secretion following the diet or training intervention and a maintenance period
Description
A Oral Glucose Tolerance Test is performed.
Time Frame
0, 12 and 52 weeks
Title
Change in oxidized lipids and lipoprotein particle size following the diet or training intervention and a maintenance period
Time Frame
0, 12 and 52 weeks
Title
Change in peak oxygen uptake (VO2max) following the diet or training intervention and a maintenance period
Description
Assessed using a bicycle ergometer
Time Frame
0, 12 and 52 weeks
Title
Change in blood pressure following the diet or training intervention and a maintenance period
Time Frame
0, 12 and 52 weeks
Title
Change in inflammatory markers in urin, blood and adipose tissue following the diet or training intervention and a maintenance period
Time Frame
0, 12 and 52 weeks
Title
Change in quality of life following the diet or training intervention and a maintenance period
Time Frame
0, 12 and 52 weeks
Title
Change in ceramides, diacylglycerol og endocannabinoid (CB)-1 receptors in adipose tissue following the diet or training intervention and a maintenance period
Time Frame
0, 12 and 52 weeks
Title
Change in hormones derived from adipose tissue following the diet or training intervention and a maintenance period
Time Frame
0, 12 and 52 weeks

10. Eligibility

Sex
All
Minimum Age & Unit of Time
45 Years
Maximum Age & Unit of Time
75 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Stable Ischemic Heart Disease BMI 28 - 40 kg/m2 Exclusion criteria: Known Diabetes Mellitus Repeated Fasting plasma glucose ≥ 7 mmol/L or Hba1c > 7 % Severe or moderate valve disease Main stem stenosis Severe heart failure, Ejection Fraction < 35 % Physical or mental disability which are expected to prevent completion of intervention Severe Chronic obstructive Pulmonary Disease (COPD) (FEV1 < 50 % of expected) or asthma Active cancer Severe kidney (GFR < 40 ml/hour) or severe liver disease Severe ischemia or arrhythmias during exercise test 2. or 3. degree atrio-ventricular (AV) block, not protected by pacemaker Organised training more than 2 times a week prior to inclusion Significant weight loss or weight gain (> 5 %)3 month prior to inclusion Not able to comprehend written and oral informed consent Hormone treatment
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Eva Prescott, MD, DMsc
Organizational Affiliation
Bispebjerg Hospital
Official's Role
Principal Investigator
Facility Information:
Facility Name
Bispebjerg Hospital
City
Copenhagen
ZIP/Postal Code
2400
Country
Denmark

12. IPD Sharing Statement

Citations:
PubMed Identifier
24252596
Citation
Pedersen LR, Olsen RH, Frederiksen M, Astrup A, Chabanova E, Hasbak P, Holst JJ, Kjaer A, Newman JW, Walzem R, Wisloff U, Sajadieh A, Haugaard SB, Prescott E. Copenhagen study of overweight patients with coronary artery disease undergoing low energy diet or interval training: the randomized CUT-IT trial protocol. BMC Cardiovasc Disord. 2013 Nov 19;13:106. doi: 10.1186/1471-2261-13-106.
Results Reference
background
PubMed Identifier
25082954
Citation
Pedersen LR, Olsen RH, Jurs A, Astrup A, Chabanova E, Simonsen L, Wisloff U, Haugaard SB, Prescott E. A randomised trial comparing weight loss with aerobic exercise in overweight individuals with coronary artery disease: The CUT-IT trial. Eur J Prev Cardiol. 2015 Aug;22(8):1009-17. doi: 10.1177/2047487314545280. Epub 2014 Jul 31.
Results Reference
background
PubMed Identifier
31575375
Citation
Pedersen LR, Olsen RH, Anholm C, Astrup A, Eugen-Olsen J, Fenger M, Simonsen L, Walzem RL, Haugaard SB, Prescott E. Effects of 1 year of exercise training versus combined exercise training and weight loss on body composition, low-grade inflammation and lipids in overweight patients with coronary artery disease: a randomized trial. Cardiovasc Diabetol. 2019 Oct 1;18(1):127. doi: 10.1186/s12933-019-0934-x.
Results Reference
derived
PubMed Identifier
26803431
Citation
Pedersen LR, Olsen RH, Anholm C, Walzem RL, Fenger M, Eugen-Olsen J, Haugaard SB, Prescott E. Weight loss is superior to exercise in improving the atherogenic lipid profile in a sedentary, overweight population with stable coronary artery disease: A randomized trial. Atherosclerosis. 2016 Mar;246:221-8. doi: 10.1016/j.atherosclerosis.2016.01.001. Epub 2016 Jan 13.
Results Reference
derived
PubMed Identifier
26296452
Citation
Pedersen LR, Olsen RH, Jurs A, Anholm C, Fenger M, Haugaard SB, Prescott E. A randomized trial comparing the effect of weight loss and exercise training on insulin sensitivity and glucose metabolism in coronary artery disease. Metabolism. 2015 Oct;64(10):1298-307. doi: 10.1016/j.metabol.2015.07.007. Epub 2015 Jul 17.
Results Reference
derived
PubMed Identifier
25802037
Citation
Olsen RH, Pedersen LR, Jurs A, Snoer M, Haugaard SB, Prescott E. A randomised trial comparing the effect of exercise training and weight loss on microvascular function in coronary artery disease. Int J Cardiol. 2015 Apr 15;185:229-35. doi: 10.1016/j.ijcard.2015.03.118. Epub 2015 Mar 11.
Results Reference
derived

Learn more about this trial

Copenhagen Study of Obese Patients With Ischemic Heart Disease Undergoing Low Energy Diet or Interval Training

We'll reach out to this number within 24 hrs